| Ranked [title] Word list | Historiographs | Help Glossary HistCite Guide About |
| Nodes: 2913, Authors: 7350, Journals: 871, Outer References: 80285, Words: 5113
Yearly output | Document Type | Language | Institution | Institution with Subdivision | Country |
| View: Overview | Sorted by LCS. |
| # | Word | Pubs | TLCS | TGCS |
|---|---|---|---|---|
| 201 | INDUCED | 10 | 64 | 200 |
| 202 | OUTCOME | 17 | 64 | 503 |
| 203 | CHEMISTRIES | 1 | 63 | 61 |
| 204 | CULPRIT | 1 | 63 | 61 |
| 205 | EFFECTS | 40 | 63 | 690 |
| 206 | LABORATORY | 33 | 63 | 829 |
| 207 | ROLE | 47 | 63 | 658 |
| 208 | UTILIZATION | 23 | 63 | 1249 |
| 209 | DIARRHEA | 30 | 62 | 455 |
| 210 | CHARACTERISTICS | 11 | 61 | 690 |
| 211 | CORONARY-CARE | 8 | 61 | 325 |
| 212 | HIV-INFECTED | 16 | 61 | 185 |
| 213 | PORCINE | 17 | 61 | 669 |
| 214 | CHANGING | 15 | 60 | 1070 |
| 215 | DECISION-ANALYSIS | 14 | 60 | 496 |
| 216 | ENDOGENOUS | 14 | 60 | 516 |
| 217 | IMMUNODEFICIENCY | 24 | 60 | 553 |
| 218 | MANAGEMENT | 46 | 60 | 753 |
| 219 | MEASURES | 19 | 60 | 425 |
| 220 | NOVEL | 23 | 60 | 311 |
| 221 | EVALUATING | 23 | 59 | 481 |
| 222 | TRIAGE | 10 | 59 | 822 |
| 223 | ANTIGENS | 19 | 58 | 304 |
| 224 | CURRENT | 29 | 58 | 830 |
| 225 | PREDICT | 6 | 58 | 384 |
| 226 | TECHNOLOGIES | 26 | 58 | 582 |
| 227 | MEDICAL-PRACTICE | 4 | 57 | 274 |
| 228 | ISCHEMIA | 12 | 56 | 636 |
| 229 | PRACTICE | 37 | 56 | 1550 |
| 230 | METHODOLOGY | 6 | 55 | 343 |
| # | Word | Pubs | TLCS | TGCS |
| 231 | PATIENT | 42 | 55 | 899 |
| 232 | RETROVIRUS | 10 | 55 | 448 |
| 233 | SPECIES | 3 | 55 | 141 |
| 234 | CAT | 9 | 54 | 200 |
| 235 | DIAGNOSIS | 44 | 54 | 614 |
| 236 | FAILURE | 9 | 54 | 195 |
| 237 | MODELING | 11 | 54 | 202 |
| 238 | STANDARD | 17 | 54 | 333 |
| 239 | EPIDEMIC | 26 | 53 | 365 |
| 240 | INDUCE | 4 | 53 | 170 |
| 241 | PREVALENCE | 13 | 53 | 185 |
| 242 | STATES | 27 | 53 | 420 |
| 243 | TRADE-OFF | 15 | 53 | 304 |
| 244 | TRAVELERS | 11 | 53 | 103 |
| 245 | XENOTRANSPLANTS | 5 | 53 | 70 |
| 246 | PIG | 10 | 52 | 265 |
| 247 | SCALING | 3 | 52 | 307 |
| 248 | WOMEN | 25 | 52 | 478 |
| 249 | DEVELOPMENT | 29 | 51 | 467 |
| 250 | DIAGNOSING | 4 | 51 | 273 |
| 251 | EFFECTIVENESS | 21 | 51 | 556 |
| 252 | GREATER | 4 | 51 | 153 |
| 253 | HOSPITALIZATION | 6 | 51 | 297 |
| 254 | NEONATAL | 15 | 51 | 236 |
| 255 | RECENT | 16 | 51 | 161 |
| 256 | ALTERNATIVE | 8 | 50 | 181 |
| 257 | BACTERIAL | 13 | 49 | 275 |
| 258 | CLINICAL-EVALUATION | 2 | 49 | 127 |
| 259 | DIFFERENCES | 11 | 49 | 589 |
| 260 | ENVIRONMENTAL | 5 | 49 | 122 |
| # | Word | Pubs | TLCS | TGCS |
| 261 | HIGHLY | 6 | 49 | 172 |
| 262 | INDUCTION | 6 | 49 | 191 |
| 263 | CLONING | 11 | 48 | 168 |
| 264 | DIMENSIONS | 2 | 48 | 100 |
| 265 | KDA | 8 | 48 | 202 |
| 266 | TUBERCULIN | 24 | 48 | 190 |
| 267 | VIEW | 7 | 48 | 255 |
| 268 | ADJUSTMENT | 2 | 47 | 208 |
| 269 | BLOCK | 4 | 47 | 134 |
| 270 | ISSUES | 37 | 47 | 715 |
| 271 | MORATORIUM | 5 | 47 | 50 |
| 272 | PULMONARY | 25 | 47 | 267 |
| 273 | ROUTINE | 16 | 47 | 366 |
| 274 | NEED | 18 | 46 | 422 |
| 275 | REPERFUSION | 3 | 46 | 176 |
| 276 | REVACCINATION | 9 | 46 | 86 |
| 277 | TEST-ORDERING | 2 | 46 | 307 |
| 278 | ADULTS | 18 | 45 | 415 |
| 279 | APPLICATION | 13 | 45 | 240 |
| 280 | DEBATE | 3 | 45 | 201 |
| 281 | DIAGNOSTIC-IMAGING | 7 | 45 | 350 |
| 282 | INTERVENTIONS | 16 | 45 | 1013 |
| 283 | ARTHRITIS | 11 | 44 | 162 |
| 284 | ASSOCIATED | 18 | 44 | 187 |
| 285 | CALL | 4 | 44 | 117 |
| 286 | CHARACTERIZATION | 9 | 44 | 357 |
| 287 | CONTENTIOUS | 1 | 44 | 168 |
| 288 | GENETIC | 9 | 44 | 490 |
| 289 | INFECTIOUS | 29 | 44 | 431 |
| 290 | MAJOR | 7 | 44 | 339 |
| # | Word | Pubs | TLCS | TGCS |
| 291 | SOCIAL | 14 | 44 | 215 |
| 292 | EARLY | 26 | 43 | 853 |
| 293 | EVIDENCE | 32 | 43 | 794 |
| 294 | MORTALITY | 25 | 43 | 478 |
| 295 | POLICY | 33 | 43 | 392 |
| 296 | TISSUE | 11 | 43 | 263 |
| 297 | DECLINE | 6 | 42 | 159 |
| 298 | FRAMEWORK | 11 | 42 | 269 |
| 299 | HEART-DISEASE | 6 | 42 | 347 |
| 300 | NATIONAL | 22 | 42 | 477 |
| 301 | PHYSICIAN | 14 | 42 | 513 |
| 302 | PRIMARY | 23 | 42 | 652 |
| 303 | PROSPECTIVE | 16 | 42 | 370 |
| 304 | QUANTITATIVE | 9 | 42 | 944 |
| 305 | ANIMAL | 7 | 41 | 134 |
| 306 | PROGRAMS | 10 | 41 | 206 |
| 307 | RESIDENTS | 3 | 41 | 270 |
| 308 | RULE | 6 | 41 | 354 |
| 309 | SECRETORY | 7 | 41 | 150 |
| 310 | STATUS | 18 | 41 | 464 |
| 311 | SURGERY | 30 | 41 | 469 |
| 312 | VIRULENT | 7 | 41 | 364 |
| 313 | ABDOMEN | 8 | 40 | 137 |
| 314 | CLINICAL-PRACTICE | 6 | 40 | 370 |
| 315 | DECISIONS | 25 | 40 | 891 |
| 316 | HOME | 2 | 40 | 314 |
| 317 | MODIFY | 1 | 40 | 251 |
| 318 | MULTIPLICATION | 1 | 40 | 88 |
| 319 | NATURAL-HISTORY | 1 | 40 | 252 |
| 320 | RESPONSE | 25 | 40 | 412 |
| # | Word | Pubs | TLCS | TGCS |
| 321 | SENSITIVITY | 5 | 40 | 215 |
| 322 | SENT | 1 | 40 | 252 |
| 323 | APPROACH | 25 | 39 | 592 |
| 324 | EVALUATIONS | 9 | 39 | 772 |
| 325 | GENERAL | 21 | 39 | 388 |
| 326 | OBSERVATIONS | 3 | 39 | 89 |
| 327 | POPULATION | 20 | 39 | 354 |
| 328 | ACTIVATOR | 4 | 38 | 473 |
| 329 | BOOSTING | 5 | 38 | 106 |
| 330 | CARDIOVASCULAR | 11 | 38 | 352 |
| 331 | CONVENTIONAL | 2 | 38 | 123 |
| 332 | COUNTRIES | 14 | 38 | 195 |
| 333 | EXPERIENCE | 23 | 38 | 396 |
| 334 | GENE | 11 | 38 | 176 |
| 335 | SUSCEPTIBLE | 2 | 38 | 116 |
| 336 | THROMBOLYTIC | 14 | 38 | 969 |
| 337 | ENDOTHELIAL | 2 | 37 | 245 |
| 338 | MAGNETIC-RESONANCE-IMAGING | 6 | 37 | 188 |
| 339 | POTENTIAL | 21 | 37 | 375 |
| 340 | PSYCHOMETRIC | 5 | 37 | 182 |
| 341 | RELATED | 17 | 37 | 226 |
| 342 | DATA | 17 | 36 | 397 |
| 343 | DELTA | 9 | 36 | 246 |
| 344 | EXAMPLES | 3 | 36 | 116 |
| 345 | M-BOVIS | 4 | 36 | 344 |
| 346 | SINGLE | 8 | 36 | 178 |
| 347 | CANCER-PATIENTS | 4 | 35 | 150 |
| 348 | CHANGES | 17 | 35 | 391 |
| 349 | CHILDHOOD | 26 | 35 | 235 |
| 350 | HEALTH-RELATED | 14 | 35 | 387 |
| # | Word | Pubs | TLCS | TGCS |
| 351 | KNOWLEDGE | 25 | 35 | 242 |
| 352 | PROGRAM | 20 | 35 | 571 |
| 353 | SUSPECTED | 21 | 35 | 345 |
| 354 | LEVEL | 9 | 34 | 189 |
| 355 | MTB | 3 | 34 | 112 |
| 356 | PATHOGENS | 5 | 34 | 231 |
| 357 | SCALE | 9 | 34 | 199 |
| 358 | SIMULATION | 3 | 34 | 34 |
| 359 | VALUES | 13 | 34 | 210 |
| 360 | VISUAL | 7 | 34 | 223 |
| 361 | ATTENUATED | 9 | 33 | 166 |
| 362 | CLINICAL-CRITERIA | 1 | 33 | 161 |
| 363 | FAMILY | 6 | 33 | 172 |
| 364 | GAMBLE | 9 | 33 | 159 |
| 365 | HOURS | 3 | 33 | 186 |
| 366 | METHODOLOGICAL | 13 | 33 | 556 |
| 367 | POLICIES | 7 | 33 | 154 |
| 368 | PUBLIC | 36 | 33 | 267 |
| 369 | VACCINIA | 3 | 33 | 109 |
| 370 | ADMITTED | 5 | 32 | 187 |
| 371 | ANGINA | 8 | 32 | 307 |
| 372 | FUSION | 6 | 32 | 90 |
| 373 | PATTERNS | 13 | 32 | 408 |
| 374 | SURVEY | 21 | 32 | 334 |
| 375 | ADMINISTRATION | 8 | 31 | 105 |
| 376 | BLEACH | 4 | 31 | 83 |
| 377 | DIAGNOSTIC-TESTS | 9 | 31 | 657 |
| 378 | ENHANCES | 5 | 31 | 144 |
| 379 | GEOGRAPHIC | 3 | 31 | 78 |
| 380 | MULTIDRUG-RESISTANT | 13 | 31 | 130 |
| # | Word | Pubs | TLCS | TGCS |
| 381 | ANKARA | 2 | 30 | 100 |
| 382 | BENEFITS | 14 | 30 | 381 |
| 383 | CLASSIFICATION | 4 | 30 | 402 |
| 384 | LARGE | 6 | 30 | 166 |
| 385 | LOW-RISK | 8 | 30 | 287 |
| 386 | MODIFIED | 5 | 30 | 105 |
| 387 | NORMAL | 8 | 30 | 194 |
| 388 | POSITIVE | 9 | 30 | 218 |
| 389 | SHORT-STAY | 2 | 30 | 152 |
| 390 | SUBUNIT | 8 | 30 | 78 |
| 391 | ACQUISITION | 4 | 29 | 43 |
| 392 | BASED | 19 | 29 | 490 |
| 393 | FUTURE-DIRECTIONS | 6 | 29 | 151 |
| 394 | INCIDENCE | 21 | 29 | 426 |
| 395 | ORDERING | 5 | 29 | 335 |
| 396 | WORKERS | 15 | 29 | 212 |
| 397 | GAMMA | 11 | 28 | 218 |
| 398 | GROUP | 13 | 28 | 290 |
| 399 | GUINEA | 9 | 28 | 83 |
| 400 | HOSPITALIZED | 6 | 28 | 96 |
Page 2 of 26: [ 1 2 3 4 5 6 7 8 9 10 ] 11 21